Is Lucid Diagnostics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: LUCD) stock is to Strong Buy LUCD stock.
Out of 2 analysts, 1 (50%) are recommending LUCD as a Strong Buy, 1 (50%) are recommending LUCD as a Buy, 0 (0%) are recommending LUCD as a Hold, 0 (0%) are recommending LUCD as a Sell, and 0 (0%) are recommending LUCD as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year LUCD price target, the average LUCD price target is $2.75, with the highest LUCD stock price forecast at $3.00 and the lowest LUCD stock price forecast at $2.50.
On average, Wall Street analysts predict that Lucid Diagnostics's share price could reach $2.75 by Mar 27, 2025. The average Lucid Diagnostics stock price prediction forecasts a potential upside of 177.78% from the current LUCD share price of $0.99.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.